Objective: To analyse the course of multiple sclerosis (MS) after fingolimod withdrawal in a multicentre cohort. Methods: Patients who discontinued fingolimod were included. Relapses, Expanded Disability Status Scale (EDSS), and new/gadolinium-enhancing lesions on magnetic resonance imaging (MRI) were assessed during the last year on...
-
2021 (v1)PublicationUploaded on: April 14, 2023
-
2019 (v1)Publication
Biologists use optical microscopes to study plankton in the lab, but their size, complexity and cost makes widespread deployment of microscopes in lakes and oceans challenging. Monitoring the morphology, behavior and distribution of plankton in situ is essential as they are excellent indicators of marine environment health and provide a...
Uploaded on: April 14, 2023 -
2021 (v1)Publication
Importance: Availability of new disease-modifying therapies (DMTs) and changes of therapeutic paradigms have led to a general improvement of multiple sclerosis (MS) prognosis in adults. It is still unclear whether this improvement also involves patients with pediatric-onset MS (POMS), whose early management is more challenging. Objective: To...
Uploaded on: March 27, 2023 -
2019 (v1)Publication
Objective: To evaluate disease activity according to rituximab (RTX) induction and maintenance regimens in a multicenter real-life dataset of NMOSD patients. Methods: This is an observational-retrospective multicentre study including patients with NMOSD treated with RTX in 21 Italian and 1 Swiss centers. Demographics, relapse rate and adverse...
Uploaded on: March 27, 2023 -
2021 (v1)Publication
Background and purpose: Real-world data on alemtuzumab are limited and do not provide evidence of its effectiveness after various disease-modifying therapies (DMTs). Our aim was to provide real-world data on the impact of clinical variables and previous DMTs on clinical response to alemtuzumab. Methods: Sixteen Italian multiple sclerosis...
Uploaded on: April 14, 2023